Target ALS – Basic Biology Consortia
Ends on 17 December 2025
Given the high unmet need for treating all ALS patients, Target ALS is soliciting proposals focused on understanding the fundamental biology of genetic and sporadic forms of ALS to help uncover the next wave of therapeutic targets. They are seeking applications from multidisciplinary groups with novel and innovative methods in convergent and complimentary multi-omic approaches, and applications of artificial intelligence and machine learning.